discontinue sulfonylurea when starting glp-1 receptor agonist Glucagon-like peptide-1 agonists (GLP-1 RA): dosing, dose Mechanism of action of sulfonylureas

Fatty Acid Modifications: Exploiting the interactions between fatty acids and albumin to achieve metabolic stability and circulation, while using the self-assembly and ionic properties of fatty acids to prolong the drugs half-life

How They Compare GLP-1 pill vs injection key differences: This comparison shows why orforglipron is being widely discussed as one of the most competitive oral GLP-1 medications to date

[DOI] [PMC free article] [PubMed] [Google Scholar] 96.Kenny P.R., Brady D.E., Torres D.M., Ragozzino L., Chalasani N., Harrison S.A

5GD Pharmaceutical Inc

No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes

However, there is little evidence that they cause congenital abnormalities in the fetuses of women taking them inadvertently around conception